Related references
Note: Only part of the references are listed.Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
AMERICAN HEART JOURNAL (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Increased IL-1β activation, the culprit not only for defective insulin secretion but also for insulin resistance?
Marianne Boeni-Schnetzler et al.
CELL RESEARCH (2011)
Globalization of Diabetes The role of diet, lifestyle, and genes
Frank B. Hu
DIABETES CARE (2011)
Genetics of type 2 diabetes: pathophysiologic and clinical relevance
Christian Herder et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Edwin J. P. van Asseldonk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes A Randomized Trial
Allison B. Goldfine et al.
ANNALS OF INTERNAL MEDICINE (2010)
The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
Rinke Stienstra et al.
CELL METABOLISM (2010)
Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes Whitehall II Prospective Cohort Study
Maren Carstensen et al.
DIABETES (2010)
Interleukin-1β May Mediate Insulin Resistance in Liver-Derived Cells in Response to Adipocyte Inflammation
Ori Nov et al.
ENDOCRINOLOGY (2010)
Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
Marina K. Roell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Prevalence of Diabetes among Men and Women in China
Wenying Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes
Christian Herder et al.
DIABETES CARE (2009)
Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
Claus M. Larsen et al.
DIABETES CARE (2009)
Islet-associated macrophages in type 2 diabetes
S. J. Richardson et al.
DIABETOLOGIA (2009)
Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
Marianne Boeni-Schnetzler et al.
ENDOCRINOLOGY (2009)
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
Adam G. Tabak et al.
LANCET (2009)
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Marc Y. Donath et al.
PHYSIOLOGY (2009)
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
J. A. Ehses et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation
Marianne Boni-Schnetzler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Increased number of islet-associated macrophages in type 2 diabetes
Jan A. Ehses et al.
DIABETES (2007)
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Richa Saxena et al.
SCIENCE (2007)
Reactivation of latent tuberculosis by TNF blockade:: The role of interferon γ
Robert S. Wallis
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2007)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression
Jennifer Jager et al.
ENDOCRINOLOGY (2007)
Low concentration of interleukin-1β induces FLICE-inhibitory protein-mediated β-cell proliferation in human pancreatic islets (Publication with Expression of Concern. See vol. 65, pg. 2462, 2016) (Publication with Expression of Concern. See vol. 65, pg. 2462, 2016) (Publication with Expression of Concern. See vol. 67, pg. 2479, 2018)
Kathrin Maedler et al.
DIABETES (2006)
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
C. Lagathu et al.
DIABETOLOGIA (2006)
Interleukin-1β and signaling of interleukin-1 in vascular wail and circulating cells modulates the extent of neointima formation in mice
J Chamberlain et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model - Pharmacotherapeutic implications
HH Chi et al.
CIRCULATION (2004)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Share Paper
